1. The journal Cancer Research is the original source of the material.2. This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open” below will launch the full-text article in another browser window
The purpose of this work was to develop an optimized liposomal formulation of topotecan for use in t...
<p><i>Context</i>: Synergistically active combinations have been used to enhance therapeutic efficac...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
Topotecan (TPT), a topoisomerase I inhibitor, is presently undergoing clinical evaluation worldwide....
Chemotherapy has been the predominant treatment modality for cancer patients, but its overall perfor...
Cancer is a life-threatening disease contributing to ~3.4 million deaths worldwide. There are variou...
In vitro cytotoxicity analysis showed ratio dependant synergism between the chemotherapeutics topote...
We have previously established a type of anti-resistant stealth liposomal topotecan plus amlodipine ...
The online version of this article, along with updated information and services, is located o
Platinum-refractory ovarian cancer is considered an incurable disease as current treatments are only...
jnci.oxfordjournals.org JNCI | Articles 53 The efficacy of most systemic chemotherapeutics is limite...
Chemotherapy of brain tumors remains a big challenge owing to the low drug transport across the bloo...
located on the World Wide Web at: The online version of this article, along with updated information...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The purpose of this work was to develop an optimized liposomal formulation of topotecan for use in t...
<p><i>Context</i>: Synergistically active combinations have been used to enhance therapeutic efficac...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
Topotecan (TPT), a topoisomerase I inhibitor, is presently undergoing clinical evaluation worldwide....
Chemotherapy has been the predominant treatment modality for cancer patients, but its overall perfor...
Cancer is a life-threatening disease contributing to ~3.4 million deaths worldwide. There are variou...
In vitro cytotoxicity analysis showed ratio dependant synergism between the chemotherapeutics topote...
We have previously established a type of anti-resistant stealth liposomal topotecan plus amlodipine ...
The online version of this article, along with updated information and services, is located o
Platinum-refractory ovarian cancer is considered an incurable disease as current treatments are only...
jnci.oxfordjournals.org JNCI | Articles 53 The efficacy of most systemic chemotherapeutics is limite...
Chemotherapy of brain tumors remains a big challenge owing to the low drug transport across the bloo...
located on the World Wide Web at: The online version of this article, along with updated information...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The purpose of this work was to develop an optimized liposomal formulation of topotecan for use in t...
<p><i>Context</i>: Synergistically active combinations have been used to enhance therapeutic efficac...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...